Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Yuan Wang

Yuan Wang, Shenzhen CN

Patent application numberDescriptionPublished
20110073736POSITIONING SYSTEM FOR A SUSPENDED MEDICAL DEVICE - A positioning system for a suspended medical device includes a positioning adjustment block fixed on a ceiling rail, a latch assembly, and a positioning assembly fixed on a trolley. The latch assembly is in a snap fit with the positioning adjustment block, and the latch assembly is connected to the positioning assembly through buffer springs.03-31-2011

Yuan Wang, Anhui CN

Patent application numberDescriptionPublished
20110077298Retinoid Derivative and Pharmaceutical Composition and Use Thereof - The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumours, such as acute leukemia, chronic leukemia, multiple myeloma and lymphoma, solid tumours, such as liver cancer, rectal cancer, mammary cancer and esophagus cancer, and skin disorders, such as psoriasis and acne.03-31-2011

Yuan Wang, Changchun CN

Patent application numberDescriptionPublished
20110062541HIGH MOLECULAR EXTINCTION COEFFICIENT METAL DYES - The present invention relates to novel compounds that are useful as ligands in organometallic dyes. More particularly, the invention relates to dyes comprising the compounds, said dyes being sensitizing dyes useful in solar cell technology. According to an embodiment, the present invention discloses new ruthenium dyes and their application in dye-sensitized solar cells (DSC). The referred ruthenium dyes with new structural features can be easily synthesized, show more than 85% light-to-electricity conversion efficiency and a higher than 9% cell efficiency.03-17-2011

Yuan Wang, Mountain Lakes, NJ US

Patent application numberDescriptionPublished
20110056848ELECTROCHEMICAL TEST SENSOR - An electrochemical test sensor for detecting the concentration of an analyte in a fluid sample. The electrochemical test sensor includes a housing that has a first end and a second opposing end. The housing includes an opening at the first end to receive a fluid test sample. An electrode assembly includes a substrate, a working electrode, a counter electrode and a reagent. The substrate has a first surface and an opposing second surface. The working electrode is disposed on the first surface of the substrate, and the counter electrode is disposed on the second surface of the substrate. The electrode assembly is positioned within the housing to define a reaction channel. The electrochemical test sensor may be used with a removable lancet mechanism or integrated within a lancet mechanism to form one integral unit.03-10-2011
20110171071Analyte Sensors, Testing Apparatus and Manufacturing Methods - In some aspects, an analyte sensor is provided for detecting an analyte concentration level in a bio-fluid sample. The analyte sensor may include a first sensor member coupled to a base, wherein the first sensor member includes a semiconductor material, a second sensor member coupled to the base; and an active region in contact with at least the first sensor member. In some aspects, the first sensor member may be a fiber, and may have a conductive core and a semiconducting cladding surrounding the core. Manufacturing methods and apparatus utilizing the sensors are provided, as are numerous other aspects.07-14-2011
20110180405Analyte Sensors, Systems, Testing Apparatus and Manufacturing Methods - In some aspects, an analyte sensor is provided for detecting an analyte concentration level in a bio-fluid sample. The analyte sensor may include one or more conductors received in a hollow portion of a hollow member. The first conductor may be made, at least in part, of a semiconductor material and an active region may be provided in contact with at least the first conductor. The analyte sensor may, in one aspect, include a lancet and an integrated sensor. Manufacturing methods and apparatus and systems utilizing the analyte sensors are provided, as are numerous other aspects.07-28-2011
20110312004TEST STRIP WITH MAGNETO-ELASTIC-RESONANCE SENSOR - A test meter system for testing a characteristic of a fluid, the test meter system including a test meter having a housing with an opening adapted to accept a test strip, an interrogation coil within the housing, a pick-up coil within the housing, and a test strip including at least one magneto-electronic-resonance sensor. When the test strip is within the opening, the interrogation coil may utilize magneto-electronic-resonance technology to interrogate the magneto-electronic-resonance sensor and the pick-up coil may be used to sense a resultant oscillation frequency of the magneto-electronic-resonance sensor, the resultant oscillation frequency associated with the characteristic. The test strip may include a plurality of sensors. The sensors may be coated with a coating sensitive to a characteristic of the fluid, where the interrogation reveals information about the fluid characteristic.12-22-2011
20120037921Electrical Devices With Enhanced Electrochemical Activity and Manufacturing Methods Thereof - In some aspects, a device is provided having a member with a region of enhanced electrochemical activity. In one aspect, a sensor of enhanced electrochemical activity is provided for detecting an analyte concentration level in a bio-fluid sample. The sensor may include a sensor member of a semiconductor material wherein the sensor member has a surface region of enhanced electrochemical activity. In other aspects, the member may be made of semiconducting foam having a surface region of enhanced electrochemical activity. In some embodiments, the region may be thermally-induced. Manufacturing methods and apparatus are also provided, as are numerous other aspects.02-16-2012
20120067734PHENOL CROSSLINK FOR SENSOR MEMBRANE - Embodiments herein provide a membrane that is a product of a phenol crosslinked with one or more compounds containing an allyl group. The phenol may be electropolymerized with the allyl-containing compounds to form the crosslinked polymer. Suitable allyl-containing compounds include allylphenol, allylalcohol, allylamine, and allylcarbamide. A membrane may have one type of allyl-containing compound, or, alternatively, two or more types of compounds. As used in an analyte sensing device, a membrane formed from a crosslinked phenol may provide improved interference exclusion, peroxide response, stability, and/or solvent resistance.03-22-2012

Yuan Wang, Shanghai CN

Patent application numberDescriptionPublished
20080230843Isolation Structure for MOS Transistor and Method for Forming the Same - A method for forming isolation structure for MOS transistor is disclosed, which includes forming a first photoresist layer over a sacrificed oxide layer of a semiconductor substrate, patterning the first photoresist layer to define a PMOS active region and a PMOS isolation region; implanting nitrogen ions into the PMOS isolation region through the sacrificed oxide layer by using the first photoresist layer as a mask; removing the first photoresist layer; forming a second photoresist layer over the sacrificed oxide layer, patterning the second photoresist layer to define a NMOS active region and a NMOS isolation region; implanting oxygen ions into the NMOS isolation region through the sacrificed oxide layer by using the second photoresist layer as a mask; removing the second photoresist layer and the sacrificed oxide layer; and annealing the semiconductor substrate to form isolation structures of PMOS and NMOS, respectively.09-25-2008
20080275055IMATINIB PRODUCTION PROCESS - Provided is a process for producing imatinib and salts thereof, e.g., imatinib mesylate. The process includes reacting4-(4-methyl-piperazin-1-ylmethyl)-benzoic acid with N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine in the presence of a carboxylic acid coupling reagent, to produce imatinib, and optionally converting the imatinib into a salt.11-06-2008
20090238843RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA.09-24-2009
20090273881Metal-Insulator-Metal Capacitor - The present invention provides a metal-insulator-metal capacitor, which comprises a semiconductor substrate; an interlayer dielectric layer disposed on the semiconductor substrate; and an insulation trench and two metal trenches all running through the interlayer dielectric layer and allowing the semiconductor substrate to be exposed; wherein the metal trenches being located on each side of the insulation trench and sharing a trench wall with the insulation trench respectively, the insulation trench being filled with insulation material as an insulation structure, the metal trenches being filled with metal material as electrodes of the capacitor.11-05-2009
20100174080NOVEL PALONOSETRON SALTS AND PROCESSES FOR PREPARATION AND PURIFICATION THEREOF - Provided are novel salts of 2-(1-azabicyclo-[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one, methods of using such salts, and processes for producing such salts07-08-2010
20110060938COMPUTER INTERLOCKING SYSTEM AND CODE BIT LEVEL REDUNDANCY METHOD THEREFOR - A code bit level redundancy method for a computer interlocking system is provided. The method includes: (1) controlling the output in parallel, and (2) sharing the collected information.03-10-2011
20110293656RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS - The invention relates to recombinant MVA which is capable of expressing structural HCV antigens, functional parts of said structural antigens or epitopes of said structural antigens. The invention further relates to a pharmaceutical composition, especially in the form of a vaccine and containing the recombinant MVA according to the invention, to eukaryotic cells that contain the inventive recombinant MVA and to various uses of the recombinant MVA, for example for producing recombinant structural proteins, for producing a pharmaceutical preparation that is suitable for the therapy and prophylaxis of HCV infections and diseases thereby caused. The invention further relates to methods for producing recombinant MVA and recombinant structural HCV polypeptides encoded by said recombinant MVA, and to DNA or RNA of said recombinant MVA.12-01-2011

Patent applications by Yuan Wang, Shanghai CN

Yuan Wang, Novi, MI US

Patent application numberDescriptionPublished
20110015902Twelve-Cornered Strengthening Member - A method for optimizing a twelve-cornered strengthening member comprises: modeling a vehicle assembly including a strengthening member having a twelve-cornered cross section; parameterizing a geometry of the strengthening member with a plurality of control parameters; defining a design of experiment using the plurality of control parameters; modeling a vehicle using the vehicle assembly; simulating a frontal impact event with the vehicle; generating a response surface based on the frontal impact event; and determining a set of optimized control parameters for the strengthening member based on the response surface.01-20-2011

Yuan Wang, Boston, MA US

Patent application numberDescriptionPublished
20100209396Method of Enhancing Proliferation and/or Hematopoietic Differentiation of Stem Cells - The present invention provides methods for inducing differentiation of a stem cell, such as an embryonic stem cell, into a hematopoietic stem cell, by expressing a cdx gene and/or a hox gene. The method is useful for generating expanded populations of hematopoietic stem cells (HSCs) and thus mature blood cell lineages. This is desirable where a mammal has suffered a decrease in hematopoietic or mature blood cells as a consequence of disease, radiation or chemotherapy.08-19-2010

Yuan Wang, Issaquah, WA US

Patent application numberDescriptionPublished
20100145923RELAXED FILTER SET - Searching for a subset of the keywords in a search-engine query is described herein. The search-engine query is parsed into keywords. The keywords are checked against an inverted index to determine whether any web documents include the subset of keywords. Documents containing the subset of keywords are listed in a search-results list and transmitted back to the user.06-10-2010

Yuan Wang, Buena Park, CA US

Patent application numberDescriptionPublished
20090199293METHOD AND SYSTEM OF MANAGING USER ACCESS IN A COMPUTING SYSTEM - A method and system of managing user access in a computing system is provided. The system can include an operations controller in communication with the computing system for managing the commercial transactions of the computing system over the internet, and an access management controller in communication with the operations controller. The access management controller can receive an input comprising user roles and actions associated with the computing system. The access management controller can generate a matrix indicating a relationship between the user roles and the actions. The access management controller can provide the input to the operations controller for implementation of access rules in accordance with the relationship indicated in the matrix. The access management controller can attempt to access in the computing system at least a portion of the user roles and actions after the operations controller has implemented the access rules. The access management controller can compares the attempted access with the relationship indicated in the matrix to determine access discrepancies.08-06-2009

Yuan Wang, Beijing CN

Patent application numberDescriptionPublished
20090124834COMPOSITE MATERIAL COMPOSED OF NANOPARTICLES OF TRANSITION METAL AND MAGNETIC FERRIC OXIDE, A METHODE OF PREPARING THE SAME, AND USES OF THE SAME - A composite material composed of nanoparticles of transition metal(s) and magnetic ferric oxide, a method of preparing the same, and uses of the same are provided. The composite material is substantially composed of nanoparticles of transition metal(s) or alloy thereof and nanoparticles of magnetic ferric oxide, the size of nanoparticles of transition metal(s) or alloy thereof is in the range of 0.7 to 5 nm, the size of nanoparticles of magnetic ferric oxide is in the range of 5 to 50 nm, and the amount of transition metal(s) or alloy thereof is in the range of 0.1 to 30 wt %, based on the total weight of composite material, the magnetic ferric oxide is gamma-Fe05-14-2009

Yuan Wang, Brossard CA

Patent application numberDescriptionPublished
20090012240Process for the preparation of amphiphilic poly(N-vinyl-2-pyrrolidone) block copolymers - The instant invention provides a two-step polymerization process for preparing amphiphilic poly(N-vinyl-2-pyrrolidone), (PVP)-block-polyester copolymers and other diblock and triblock copolymers consisting of PVP as one block. The block copolymers of the invention can be used as vehicles for drug delivery.01-08-2009

Patent applications by Yuan Wang, Brossard CA

Yuan Wang, Wuhan CN

Patent application numberDescriptionPublished
20110166201MIRNAS AS THERAPEUTIC TARGETS IN CANCER - MicroRNAs (miRNAs) are a class of non-coding small RNA molecules that regulate gene expression at the post-transcriptional level by interacting with 3′ untranslated regions (UTRs) of their target mRNAs. The invention relates to the application of miR-192 and miR-215. Both of these miRNAs impact cellular proliferation through the p53-miRNA circuit, and interact with dihydrofolate reductase (DHFR) and thymidylate synthase (TS). Particularly, upregulation of these miRNAs reduces cellular proliferation. The invention relates to this discovery. For example, inhibiting miR-192 and/or miR-215 sensitizes a neoplasm or a subject with a neoplasm to chemotherapeutic agents. Furthermore, measuring the levels of miR-192 and/or miR-215 provides one with information regarding whether the neoplasm or subject will respond to chemotherapeutic agents. Accordingly, the invention relates to composition and methods relating to the identification, characterization and modulation of the expression of miR-192 and miR-215.07-07-2011

Yuan Wang, Shangai CN

Patent application numberDescriptionPublished
20110306792PROCESS FOR PREPARING TOLTERODINE AND THE L-TARTRATE THEREOF - The present invention relates to a process for preparing tolterodine and the L-tartrate thereof. The preparation consists of the following steps: A) ammonolysis reaction between diisopropylamine and compound 2 (3,4-dihydro-6-methyl-4-phenyl-2H-benzopyran-2-one) activated by an activator to afford the amide 3; B) reduction of the amide by a reductant to give compound 1, i.e., racemic tolterodine free base; C) Resolution of the tolterodine free base to afford tolterodine L-tartrate. The present route is very short and suitable for industrial production.12-15-2011

Yuan Wang, Liaoning CN

Patent application numberDescriptionPublished
20120076602Transverse-Longitudinal Perpendicular Automatic Adjusting Apparatus - A transverse-longitudinal perpendicular automatic adjusting apparatus used for a cutting machine is disclosed. The automatic adjusting apparatus comprises a cross beam (03-29-2012

Yuan Wang, Hubei CN

Patent application numberDescriptionPublished
20120087992miRNAS AS THERAPEUTIC TARGETS IN CANCER - Methods for modulating expression of a component of a cell, comprising contacting the cell with a nucleic acid comprising an miR-140 nucleic acid sequence in an amount sufficient to modulate the cellular component are provided. Overexpression of miR-140 inhibits cell proliferation in both U-2 OS (wt-p53) and HCT 116 (wt-p53) cell lines. Cells transfected with miR-140 are more resistant to chemotherapeutic agent methotrexate, mi-140 expression is related to HDAC4 protein expression. The claimed methods reduce the protein expression level of HDAC4 without degrading the target mRNA.04-12-2012

Yuan Wang, Sammamish, WA US

Patent application numberDescriptionPublished
20120233096OPTIMIZING AN INDEX OF WEB DOCUMENTS - Historical usage data related to user queries and training properties for a plurality of web pages is received and utilized to train a mathematical model to predict the likelihood of retrieval of a web page during a web search. Properties are extracted from the plurality of web pages in the index and the mathematical model is applied to the properties for each web page to calculate a sortrank value. The index is reordered based on the sortrank value such that the web pages most likely to be retrieved by a user submitting a search query appear first in the index. After a search query is received from a user the index is traversed in an order determined by the sortrank value. Responsive web pages are presented to the user in an order determined by a search engine ranking algorithm.09-13-2012